Company / Net Income
Silo Pharma, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$4.4M
FY2025
5-year range
-$4.4M / -$969.5K
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$4M to -$4M over the past 2 years.
Based on SEC 10-K filings.
-$4M in FY2025.
Declined from -$4M to -$4M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 18.7% year-over-year.
- Peak net income was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.4M | -18.7% |
| FY2024 | -$3.7M | +5.3% |
| FY2023 | -$3.9M | -285.7% |
| FY2020 | -$1.0M | -4.5% |
| FY2019 | -$969.5K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026